Fri.Apr 11, 2025

article thumbnail

FDA Grants Fast Track Designation for Potential Bird Flu Vaccine

Drug Topics

The designation addresses the unmet need for prevention of H5N1, which remains a global health risk, and a phase 1 trial of the vaccine was initiated in November 2024.

Vaccines 691
article thumbnail

STAT+: FDA plans to phase out animal testing in drugs in what it calls a ‘paradigm shift’

STAT

In an unexpected move, the U.S. Food and Drug Administration announced plans this week to reduce — and possibly replace — animal testing with other methods for developing certain medicines in a bid to lower R&D costs and, eventually, the prices for prescription drugs. The agency will encourage researchers to use computer modeling and artificial intelligence to predict how a drug will perform, as well as organs-on-a-chip, which are miniaturized devices that mimic organs and tiss

FDA 141
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Expanding the Pharmacy: How Collaborative Practice Agreements Can Improve Patient Outcomes

Drug Topics

Collaborative practice agreements enable pharmacists to leverage their expertise beyond traditional dispensing, but barriers continue to limit their implementation.

363
363
article thumbnail

Pharma’s manufacturing moment: Where companies are making the biggest moves

PharmaVoice

The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.

259
259
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Preparedness Key For Delivering Excellent Patient Care in Pharmacies | AAP 2025

Drug Topics

A conversation with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, at the American Associated Pharmacies 2025 Annual Conference.

article thumbnail

NICE recommends new combination breast cancer drug

European Pharmaceutical Review

The National Institute For Health and Care Excellence ( NICE )s has recommended a new combination treatment for advanced breast cancer patients. AstraZenecas Truqap (capivasertib) in combination with fulvestrant is indicated as a treatment option for around 1,100 UK adults with hormone receptor (HR)-positive HER2-negative breast cancer with certain genetic mutations.

More Trending

article thumbnail

Doctors remove pig kidney from an Alabama woman after a record 130 days

STAT

WASHINGTON — An Alabama woman who lived with a  pig kidney  for a record 130 days had the organ removed after her body began rejecting it and is back on dialysis, doctors announced Friday — a disappointment in the ongoing quest for animal-to-human transplants. Towana Looney  is recovering well from the April 4 removal surgery at NYU Langone Health and has returned home to Gadsden, Alabama.

101
101
article thumbnail

GLP-1s Present Profitability Challenges to Independent Pharmacies | AAP 2025

Drug Topics

A conversation with Scott Biggs and Greg Mitchell at the American Associated Pharmacies 2025 Annual Conference.

article thumbnail

A Question of Soul: A Pharmacist Confronts Himself and His Profession

Pharmacy Times

In business, growth for the sake of growth mirrors the ideology of the cancer cell.

122
122
article thumbnail

Frustration in Community Pharmacy Highlights Tainted Benefits System

Drug Topics

David Blair, CEO of LucyRx, discusses the common challenges his clients face and how his companys innovative model can help them overcome financial hurdles.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

68
article thumbnail

Navigating Legal and Billing Challenges in Pharmacists’ Clinical Services

Drug Topics

Dae Lee, PharmD, Esq, CPBS, discusses the legal and billing challenges hindering pharmacy practices and opportunities to overcome them.

247
247
article thumbnail

SEO Marketing Strategies that work in Pharma

Pharma Marketing Network

In a highly regulated industry like pharmaceuticals, standing out online can feel like navigating a maze. Unlike retail or tech brands, pharma companies must balance compliance with creativity while communicating with multiple audiences. This is where SEO marketing strategies become essentialallowing brands to boost visibility, earn trust, and support both HCP and patient journeys without violating regulatory guidelines.

article thumbnail

FDA Approves Nonopioid Pain Medication in Novel Class for Treatment of Acute Pain

Drug Topics

The new approval is the first nonopioid option for moderate to severe acute pain in adults.

FDA 247
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA to phase out animal testing with AI and lab-based models

Pharmaceutical Technology

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

FDA 98
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

In a letter sent to states, designated state health program requests with a healthcare-adjacent focus are unlikely to be approved, CMS announced. Here's what that means.

90
article thumbnail

AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use

Pharmaceutical Technology

The twice daily tablet represents a significant step forward for patients with advanced breast cancer.

94
article thumbnail

Lower Vitamin K Levels Associated with Impaired Learning and Memory in Mice

Pharmacy Times

Rather than turning to vitamin K supplements, individuals should incorporate more vegetables into their diets.

86
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Alzheon Alzheimer's hopes dented by trial readout

pharmaphorum

Alzheon has been left sifting through data from a failed Alzheimer's trial for crumbs of evidence that its oral therapy may have some efficacy

84
article thumbnail

FDA Approves Nivolumab With Ipilimumab for First-Line Treatment of Adult Patients With HCC

Pharmacy Times

Patients with unresectable or metastatic hepatocellular carcinoma (HCC) receiving this regimen had favorable median overall survival (23.7 months) compared with standard of care (20.6 months).

FDA 81
article thumbnail

Novartis plans $23bn manufacturing, R&D spend in US

pharmaphorum

Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there

83
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The American Medical Association is seeking answers from Optum after reports from physicians indicated that the company pressuring them to repay loans issued following the cyberattack on Change Healthcare.

76
article thumbnail

RFK Jr unorthodox vaccine views on show in interview

pharmaphorum

Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview that touched on delays to a COVID-19 shot review

article thumbnail

AZD0780, Novel Oral PCSK9 Inhibitor, Demonstrates Major LDL Cholesterol Reductions

Pharmacy Times

When used in combination with background statin therapy, AZD0780 resulted in major reductions in low-density lipoprotein cholesterol (LDL-C) and achievements of guideline-recommended LDL-C goals.

73
article thumbnail

FDA plans to phase out animal testing for antibodies

pharmaphorum

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.

FDA 66
article thumbnail

Measuring Impact Without Adding Burden: Finding Meaning in Metrics

Pharmacy Times

Metrics should empower pharmacists rather than burden them.

73
article thumbnail

Pill that can slow breast cancer cleared for NHS use

pharmaphorum

AstraZeneca's oral drug Truqap will soon be available for people with advanced breast cancer via the NHS in England, as long as testing is available

59
article thumbnail

Pharmacists Play Key Role in Managing Toxicity During Neoadjuvant Therapy for Melanoma

Pharmacy Times

Christine Barrett, PharmD, BCOP, shares insights, challenges, and advice for oncology pharmacists navigating neoadjuvant therapy.

65
article thumbnail

Pharma Pulse 4/11/25: Long-Term Sustainability for Diverse Trial Initiatives, Payers Consider Policy Options for GLP-1 Access & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

59
article thumbnail

Expanding Roles for Pharmacy Technicians in Ambulatory Oncology

Pharmacy Times

Jessica Davis, PharmD, BCOP highlights the role of pharmacy technicians in ambulatory oncology clinic settings.

65
article thumbnail

Hubs East 2025: Building a Thriving Culture

Pharmaceutical Commerce

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, comments on another presentation that has caught her eye at the conference.

59
article thumbnail

Study Finds Reduction in RSV Hospitalizations Among Vaccinated Older Adults in England

Pharmacy Times

The findings suggest a positive impact of RSV vaccination on RSV-associated hospital admission, emphasizing the importance of protection in this population.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

All told, CMS said it expects the proposed updates will raise hospitals total payments by $4 billion, a tally that includes a $1.5 billion projected increase in Medicare uncompensated care payments to disproportionate share hospitals. The proposed hospital pay rule for also looks at reducing regulatory burden, updating quality measurement and furthering MAHA goals.